Search for Clinical Trial Results
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT Condition:
|
Recruiting |
Study Name: Myeloproliferative Neoplasms (MPNs) Patient Registry Condition:
|
Recruiting |
Study Name: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia Condition:
Interventions:
|
Withdrawn |
Study Name: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) Condition:
|
Completed |
Study Name: Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders Condition:
Interventions: |
Withdrawn |
Study Name: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant Condition:
|
Completed |
Study Name: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Condition:
|
Completed |
Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition:
Interventions: |
Completed |
Study Name: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Condition:
Interventions: |